GB201900526D0 - Bicyclic peptide ligands specific for caix - Google Patents
Bicyclic peptide ligands specific for caixInfo
- Publication number
- GB201900526D0 GB201900526D0 GBGB1900526.3A GB201900526A GB201900526D0 GB 201900526 D0 GB201900526 D0 GB 201900526D0 GB 201900526 A GB201900526 A GB 201900526A GB 201900526 D0 GB201900526 D0 GB 201900526D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- caix
- peptide ligands
- ligands specific
- bicyclic peptide
- bicyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1900526.3A GB201900526D0 (en) | 2019-01-15 | 2019-01-15 | Bicyclic peptide ligands specific for caix |
| EP20701119.8A EP3911743A1 (en) | 2019-01-15 | 2020-01-15 | Bicyclic peptide ligands specific for caix |
| JP2021563433A JP2022517442A (ja) | 2019-01-15 | 2020-01-15 | Caixに特異的な二環式ペプチドリガンド |
| CN202080009486.9A CN113383074A (zh) | 2019-01-15 | 2020-01-15 | Caix特异性的双环肽配体 |
| US17/422,933 US20220133732A1 (en) | 2019-01-15 | 2020-01-15 | Bicyclic peptide ligands specific for caix |
| PCT/GB2020/050070 WO2020148526A1 (en) | 2019-01-15 | 2020-01-15 | Bicyclic peptide ligands specific for caix |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1900526.3A GB201900526D0 (en) | 2019-01-15 | 2019-01-15 | Bicyclic peptide ligands specific for caix |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201900526D0 true GB201900526D0 (en) | 2019-03-06 |
Family
ID=65528170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1900526.3A Ceased GB201900526D0 (en) | 2019-01-15 | 2019-01-15 | Bicyclic peptide ligands specific for caix |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220133732A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3911743A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022517442A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113383074A (cg-RX-API-DMAC7.html) |
| GB (1) | GB201900526D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020148526A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ731185A (en) | 2014-10-29 | 2024-03-22 | Bicyclerd Ltd | Bicyclic peptide ligands specific for mt1-mmp |
| WO2019002842A1 (en) | 2017-06-26 | 2019-01-03 | Bicyclerd Limited | BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF |
| JP7670481B2 (ja) | 2017-08-04 | 2025-04-30 | バイスクルテクス・リミテッド | Cd137に対して特異的な二環式ペプチドリガンド |
| CA3091775A1 (en) | 2018-02-23 | 2019-08-29 | Bicycletx Limited | Multimeric bicyclic peptide ligands |
| US11180531B2 (en) | 2018-06-22 | 2021-11-23 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 |
| GB201820295D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for MT1-MMP |
| GB201820325D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for psma |
| GB201820288D0 (en) | 2018-12-13 | 2019-01-30 | Bicycle Tx Ltd | Bicycle peptide ligaands specific for MT1-MMP |
| WO2020128527A1 (en) | 2018-12-21 | 2020-06-25 | Bicyclerd Limited | Bicyclic peptide ligands specific for pd-l1 |
| EP3897849A1 (en) | 2018-12-21 | 2021-10-27 | BicycleTx Limited | Bicyclic peptide ligands specific for pd-l1 |
| GB201900529D0 (en) | 2019-01-15 | 2019-03-06 | Bicycletx Ltd | Bicyclic peptide ligands specific for CD38 |
| TWI860386B (zh) | 2019-07-30 | 2024-11-01 | 英商拜西可泰克斯有限公司 | 異質雙環肽複合物 |
| CN116348476A (zh) | 2020-08-03 | 2023-06-27 | 拜斯科技术开发有限公司 | 基于肽的接头 |
| EP4448544A2 (en) | 2021-12-17 | 2024-10-23 | 3B Pharmaceuticals GmbH | Carbonic anhydrase ix ligands |
| EP4321526A4 (en) * | 2022-02-11 | 2026-04-15 | C Biomex Co Ltd | Peptide ligand targeting carbonic anhydrase IX, peptide construction comprising it, and associated uses |
| WO2024041532A1 (zh) * | 2022-08-22 | 2024-02-29 | 赣州和美药业股份有限公司 | 含四价铂的配合物、前药及其制备方法和应用 |
| CN120943901A (zh) * | 2025-05-29 | 2025-11-14 | 北京肿瘤医院(北京大学肿瘤医院) | 经修饰的caix靶向环肽、核素标记物及其在肿瘤诊疗方面的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| ES2428869T3 (es) | 2005-01-24 | 2013-11-12 | Pepscan Systems B.V. | Compuestos de unión, compuestos inmunógenos y peptidomiméticos |
| JP6074574B2 (ja) | 2008-02-05 | 2017-02-08 | バイシクル セラピューティクス リミテッド | 方法及び組成物 |
| NZ731185A (en) | 2014-10-29 | 2024-03-22 | Bicyclerd Ltd | Bicyclic peptide ligands specific for mt1-mmp |
| GB201607827D0 (en) * | 2016-05-04 | 2016-06-15 | Bicycle Therapeutics Ltd | Bicyclic peptide-toxin conjugates specific for MT1-MMP |
| EP3615550A1 (en) * | 2017-04-27 | 2020-03-04 | BicycleTx Limited | Bicyclic peptide ligands and uses thereof |
| WO2019002842A1 (en) * | 2017-06-26 | 2019-01-03 | Bicyclerd Limited | BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF |
-
2019
- 2019-01-15 GB GBGB1900526.3A patent/GB201900526D0/en not_active Ceased
-
2020
- 2020-01-15 JP JP2021563433A patent/JP2022517442A/ja active Pending
- 2020-01-15 EP EP20701119.8A patent/EP3911743A1/en not_active Withdrawn
- 2020-01-15 US US17/422,933 patent/US20220133732A1/en not_active Abandoned
- 2020-01-15 WO PCT/GB2020/050070 patent/WO2020148526A1/en not_active Ceased
- 2020-01-15 CN CN202080009486.9A patent/CN113383074A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022517442A (ja) | 2022-03-08 |
| WO2020148526A1 (en) | 2020-07-23 |
| EP3911743A1 (en) | 2021-11-24 |
| US20220133732A1 (en) | 2022-05-05 |
| CN113383074A (zh) | 2021-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201900525D0 (en) | Bicyclic peptide ligands specific for caix | |
| ZA202100442B (en) | Bicyclic peptide ligands specific for nectin-4 | |
| IL287881A (en) | Ox40-specific bicyclic peptide ligands | |
| IL290089A (en) | Heterotandem bicyclic peptide complexes | |
| HUE072242T2 (hu) | Heterotandem biciklusos peptidkomplexek | |
| GB201820325D0 (en) | Bicyclic peptide ligands specific for psma | |
| GB201900530D0 (en) | Bicyclic peptide ligands specific for CD38 | |
| GB201900529D0 (en) | Bicyclic peptide ligands specific for CD38 | |
| SG11202002261VA (en) | Novel bispecific polypeptide complexes | |
| GB201820320D0 (en) | Bicyclic peptide ligands specific for FAPalpha | |
| GB201918495D0 (en) | Bicyclic peptide ligands specific for il-46 | |
| GB201904632D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
| GB201918488D0 (en) | Bicyclic peptide ligands specific for chymase | |
| GB201818499D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
| GB201815684D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
| GB201905631D0 (en) | Bicyclic peptide ligands specific for pd-l1 | |
| GB201904622D0 (en) | Bicyclic peptide ligands specific for pd-l1 | |
| GB201904621D0 (en) | Bicyclic peptide ligands specific for PD-L1 | |
| GB201918489D0 (en) | Bicyclic peptide ligands specific for hsp90 | |
| GB201918559D0 (en) | Bicyclic peptide ligands specific for IL-17 | |
| GB201918558D0 (en) | Bicyclic peptide ligands specific for IL-17 | |
| GB201918557D0 (en) | Bicyclic peptide ligands specific for IL-17 | |
| HK40050152A (en) | Bicyclic peptide ligands specific for nectin-4 | |
| GB201918496D0 (en) | Bicyclic peptide ligands specific for klk5 | |
| GB201818603D0 (en) | Bicyclic peptide ligands specific for epha2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |